To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

The advice to “eat less, move more” isn’t just outdated, it’s harmful. Obesity is a chronic condition shaped by biology, ...

A new study has made the case for synching your daily calories with your own circadian rhythm to improve glucose metabolism, ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...